Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 56,328 AGMB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | AgomAb Therapeutics NV (AGMB) | Grant/Award | 56,328 | n/a |
| Jun 2, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 22,000 | n/a |
| Jun 1, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 10,000 | n/a |
| Mar 24, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 38,499 | n/a |
| Mar 17, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 8,125 | n/a |
| Jan 27, 2026 | CRISPR Therapeutics AG (CRSP) | Purchase | 1,508 | $49.7K |
| Oct 3, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 16,500 | n/a |
| Jun 4, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 25,000 | n/a |
| May 30, 2025 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 10,000 | n/a |
| Mar 18, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 46,667 | n/a |